Related Experiment Videos

Scenario of mushroom poisoning in a tertiary care hospital

V A Syed1, R Lakshmi, P Karki

  • 1Department of Internal Medicine, BP Koirala Institute of Health Sciences, Dharan, Nepal.

JNMA; Journal of the Nepal Medical Association
|November 26, 2010
PubMed
Abstract

Insights

Mushroom poisoning in Nepal is often unintentional and linked to wild mushroom consumption. Public awareness campaigns are crucial for prevention and reducing severe outcomes like liver failure.

Area of Science:

  • Toxicology
  • Public Health
  • Clinical Medicine

Background:

  • Mushroom poisoning is a recurring issue in Nepal, with many cases going unreported.
  • This study investigates the patterns and consequences of toxic mushroom ingestion.

Purpose of the Study:

  • To evaluate the clinical presentation and outcomes of mushroom poisoning cases.
  • To identify risk factors and inform preventative strategies.

Main Methods:

  • Retrospective analysis of 27 patients admitted to BPKIHS (2002-2006).
  • Diagnosis based on patient history and clinical symptoms.
  • Data collected on demographics, ingestion details, symptoms, and treatment outcomes.

Main Results:

  • All 27 patients (7-83 years) unintentionally consumed wild mushrooms.
  • Symptoms onset ranged from within 1 hour to 6 hours.
  • Common symptoms included nausea (100%), vomiting (88.88%), and diarrhea (62.96%).
  • Three patients developed severe hepatitis, with one fatality due to acute liver failure.

Conclusions:

  • Mushroom poisoning in this cohort was primarily acute, unintentional, and associated with wild mushroom consumption.
  • Community awareness programs are essential for preventing poisoning incidents.

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Tertiary Healthcare System01:21

Tertiary Healthcare System

Specialized care provided over an extended period is called tertiary care. Usually, a primary or secondary care physician will refer a patient to tertiary care. A patient's maximum physical and mental function is restored in tertiary care, which is caused due to the impact of a chronic illness or condition. Tertiary care aims to achieve the highest level of functioning possible while managing chronic illness. For example, a patient who falls and fractures their hip will need secondary care to...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...